Sanofi Builds US-based Consumer Powerhouse in Preparation for Allegra OTC Switch
Executive Summary
Sanofi-Aventis' $1.8 billion bid for over-the-counter and personal care product firm Chattem Inc. offers the French firm a coveted toehold in the sizeable US consumer health care market while also opening potential opportunities in emerging markets. As such, the deal is in line with the French pharma's emphasis on diversification, helping the company hedge the development risks associated with its branded pharmaceuticals.
You may also be interested in...
Pharma Firm ISO OTC Switch Partner; NDA Experience, Resources Needed
Success in OTC switches can hinge on finding the right partner, say switch consultants during a CHPA webinar. Due diligence in negotiations can help determine if a potential partner is the right fit for the time- and labor-intensive processes.
Pharma Firm ISO OTC Switch Partner; NDA Experience, Resources Needed
Success in OTC switches can hinge on finding the right partner, say switch consultants during a CHPA webinar. Due diligence in negotiations can help determine if a potential partner is the right fit for the time- and labor-intensive processes.
Novartis Eyes Full, $50 billion Alcon Takeover
Novartis on Jan 4 announced it was exercising its option to purchase Nestlé's remaining 52 percent stake in eye-care group Alcon for $28.1 billion. The Swiss Big Pharma will finish up paying almost $50 billion for full control of the group, given its controversial attempt to buy out the minority Alcon shareholders for a further $11.2 billion.